Over the past three years, Advancements in healthcare, biotechnology, pharmaceuticals, and healthcare technologies have progressed at an unprecedented pace. With the global awareness of health and treatment steadily increasing, we have witnessed technological advancements that would typically take decades, occurring in a matter of months, thanks to the integration of AI with biopharmaceutical technologies. By investing in health innovations, we have seen the potential to enable humans to maintain optimal physical health and treat aging as a disease, thereby fostering the possibility of a long, healthy, and happy life.
Looking to the future, we envision a world where beneficial bioactive substances guide the body to a healthy state, and healthcare devices monitor and maintain the body’s stability. Through the integration of individual medical data and health information onto a unified platform, we will provide personalized healthcare services. Moreover, with AI-driven recommendations and big data research, the pace of medical advancements will accelerate and automate at an unprecedented rate.
Through our organoid bank, we focus on culturing artificial organs and tissue to replace and heal defective body parts. Additionally, we are working on optimizing the gut microbiome to regulate metabolic functions, striving to free humanity from the constraints of disease.
We are committed to continually removing the factors that contribute to aging and reversing cellular time through partial cellular reprogramming. Our vision is to extend human life expectancy and usher in a generation of everlasting youth—the Everlasting Generation.
Utilizing bioactive substance to guide the human body towards an optimal state of health.
Monitoring and maintaining a stable and defect-free physical condition through advanced healthcare devices.
Integrating individual medical data into the HDC platform and incorporating AI to deliver personalized healthcare services and automate, expedite medical research.
Facilitating tissue repair through organoid-based artificial organs and cell tissue transplants, with an organoid bank for producing and supplying organoid-based products for research and clinical purposes.
Investigating Intestinal microbiome signaling pathways to regulate metabolism and address chronic diseases and disorders.
Dramatically extending absolute human lifespan by removing intrinsic and extrinsic stress factors contributing to aging.
Reversing biological age through partial cellular reprogramming to effectively turn back the body’s biological clock.
Developing a multifactorial anti-aging vaccine to establish a new generation, “Evergen,” immune to aging.
Creating and distributing the "Cell Life Rebalancer," a device that enables continuous and systematic aging management.
Influence of Microenvironmental Orchestration on Multicellular Lung Alveolar Organoid Development from Human Induced Pluripotent Stem Cells
Induced pluripotent stem cells (iPSCs) have emerged as promising in vitro tools, providing a robust system for disease modelling and facilitating drug screening. Human iPSCs have been successfully differentiated into lung cells and three-dimensional lung spheroids or organoids. The lung is a multicellular complex organ that develops under the symphonic
